Regulatory Immunotherapy in Bone Marrow Transplantation
Every year individuals receive hematopoietic stem cell transplantation (HSCT) to eradicate malignant and nonmalignant disease. The immunobiology of allotransplantation is an area of ongoing discovery, from the recipient's conditioning treatment prior to the transplant to the donor cell populati...
Saved in:
Main Authors: | Vanessa Morales-Tirado, Wioleta Luszczek, Marié van der Merwe, Asha Pillai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2011/768948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the visibility and public engagement of bone marrow and stem cell transplantation research: An altmetric analysis
by: Mohammad Ahmadian, et al.
Published: (2025-02-01) -
Haematopoietic Stem Cell Transplant Trends in Pakistan: Activity Survey from Pakistan Bone Marrow Transplant Group
by: Natasha Ali, et al.
Published: (2023-01-01) -
Association of Human Lymphocyte Antigens with Obstructive Airways Disease after Bone Marrow Transplantation
by: David Spaner, et al.
Published: (1996-01-01) -
Fatal Fulminant Hepatic Failure from Adenovirus in Allogeneic Bone Marrow Transplant Patients
by: Jatin M. Vyas, et al.
Published: (2012-01-01) -
Efficacy of Surgery Combined with Autologous Bone Marrow Stromal Cell Transplantation for Treatment of Intracerebral Hemorrhage
by: Jianxin Zhu, et al.
Published: (2015-01-01)